Researchers at The University of Nottingham have taken some important first steps to creating a synthetic copycat of a living cell, a leading science journal reports.
Dr Cameron Alexander and PhD student George Pasparakis in the University's School of Pharmacy have used polymers — long-chain molecules — to construct capsule-like structures that have properties mimicking the surfaces of a real cell.
In work published as a 'VIP paper' in the journal
Angewandte Chemie International Edition, they show how in the laboratory they have been able to encourage the capsules to 'talk' to natural bacteria cells and transfer molecular information.
The breakthrough could have a number of potential medical uses. Among them could be the development of new targeted drug delivery systems, where the capsules would be used to carry drug molecules to attack specific diseased cells in the body, while leaving healthy cells intact, thereby reducing the number of side affects that can be associated with treatments for life-threatening illnesses such as cancer.
The technology could also be used as an anti-microbial agent, allowing doctors to destroy harmful bacteria, without attacking other health-promoting bacteria in the body, which could offer a new weapon in the fight against superbugs.
Dr Cameron Alexander said: “These are very primitive steps in the lab, and still a long way from a true synthetic counterpart to a biological cell, but we have demonstrated that we can transfer certain molecules from inside the synthetic capsule to the bacteria when they are in physical contact, which is an exciting development.
“It's extremely early stages, but it's a move closer to the big experiment when we can one day ask whether a natural cell can think a synthetic cell is one of its own.”
The work has been funded through the IDEAS Factory programme run by the Engineering and Physical Sciences Research Council (EPSRC), which aims to promote blue sky, curiosity-led research. It comes ahead of the launch of one of the UK's first research networks into synthetic biology, which is led by Nottingham computer scientists and pharmacists with chemists at Oxford and Glasgow universities. The network, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the EPSRC Life Sciences Interface Programme, involves collaboration across six centres and includes scientific and ethics experts in the emerging field of synthetic biology.
The paper, entitled Sweet-talking Double Hydrophilic Block Copolymer Vesicles, can be accessed online at
http://dx.doi.org/10.1002/anie.200801098
Source: University of Nottingham
Related stories:
Atomic structure of the mammalian 'fatty acid factory' determined
Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders. Now researchers at ETH Zurich have determined the atomic structure of a mammalian fatty acid synthase. Their results have just been published in
Science magazine.
Key site in iron metabolism aids in diagnosing anemia of chronic disease
University of Utah School of Medicine researchers have developed a new tool that facilitates diagnosis of anemia related to chronic illness, as well as diseases of iron overload. The results of a study detailing the new tool are published in the August 2008 issue of the journal
Cell Metabolism, a publication of Cell Press.
Abortion drug's off-label use may have led to deaths
Preliminary U-M studies indicate that oral use of RU-486's companion drug misoprostol is safe, but vaginal use may undermine body's immune responses. The off-label use of a drug given with RU-486 to terminate a pregnancy may be responsible for a handful of rare, fatal infections seen in women taking the drugs since 2000, a study by University of Michigan scientists suggests.
Intestinal Bacteria Promote and Prevent Inflammatory Bowel Disease
Scientists search for drug candidates in some very unlikely places. Not only do they churn out synthetic compounds in industrial-scale laboratories, but they also scour coral reefs and scrape tree bark in the hope of stumbling upon an unsuspecting molecule that just might turn into next year’s big block buster. But one region that scientists have not been searching is their guts. Literally.
Protein Fibrils as Alternative Plastics?
Amyloid deposits in tissues and organs are linked to a number of diseases, including Alzheimer’s, Parkinson’s, type II diabetes, and prion diseases such as BSE. However, amyloids are not just pathological substances; they have potential as a nanomaterials.
Novel living system recreates predator-prey interaction
The hunter-versus-hunted phenomenon exemplified by a pack of lionesses chasing down a lonely gazelle has been recreated in a Petri dish with lowly bacteria.
Cow stomach holds key to turning corn into biofuel
An enzyme from a microbe that lives inside a cow’s stomach is the key to turning corn plants into fuel, according to Michigan State University scientists.
Synthetic peptoids hold forth promise for new antibiotics
Drug-resistant bacterial infections are a growing concern, and much research has been devoted to finding new classes of antibiotics to fight them.